Abstract: In one aspect, the invention relates to compositions comprising stapled peptides, methods of making same, pharmaceutical compositions comprising same, and methods of treating various diseases, including, but not limited to, metabolic disorders such as diabetes, and cancers. The disclosed compounds comprise stapled peptides, including, but not limited to, stapled glucagon, axin, and p53 peptide homologues, which are useful as therapeutic agents for a variety of diseases as disclosed herein. The disclosed methods are useful in the preparation of a variety of stapled peptides, including stapled peptide homologues of glucagon, axin, and p53. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: The application discloses multimeric assemblies including multiple oligomeric substructures, where each oligomeric substructure includes multiple proteins that self-interact around at least one axis of rotational symmetry, where each protein includes one or more polypeptide-polypeptide interface (“O interface”); and one or more polypeptide domain that is capable of effecting membrane scission and release of an enveloped multimeric assembly from a cell by recruiting the ESCRT machinery to the site of budding by binding to one or more proteins in the eukaryotic ESCRT complex (“L domain”); and where the multimeric assembly includes one or more subunits comprising one or more polypeptide domain that is capable of interacting with a lipid bilayer (“M domain”), as well as membrane-enveloped versions of the multimeric assemblies.

Abstract: A cathode (100) for use in a lithium-air battery can include a polymer binder (150) having a conductive material (120), phyllosilicate nanoparticles (110), a lithium salt (130), and a metal catalyst (140) distributed in the polymer binder (150). The cathode (100) can be porous to allow oxygen to diffuse from surrounding air into the cathode (100). A lithium-air battery can include a lithium metal anode, a solid electrolyte in contact with the lithium metal anode, and a cathode (100) in contact with the solid electrolyte. The cathode (100) can have a polymer binder (150) as a support matrix. The polymer binder (150) can be porous to allow oxygen to diffuse from surrounding air into the cathode (100). The cathode (100) can include the polymer binder (150), a conductive material (120), phyllosilicate nanoparticles (110), a lithium salt (130), and a metal catalyst (140) distributed in the polymer binder (150).

Abstract: Methods, devices, and kits are provided for performing PCR and other thermal cycling reactions in <20 seconds per cycle, using induction heating.

Abstract: Methods, devices, and kits are provided for performing PCR in <20 seconds per cycle, with improved efficiency and yield.

Abstract: Devices, systems, and methods for measuring the blood loss of a subject during a medical procedure. Blood and other fluids are received within a container, and a blood measurement device determines the hemoglobin concentration of the fluid within the container. The blood measurement device can also calculate the estimated blood loss of the subject based upon the determined hemoglobin concentration and the volume of the fluid within the container and the patient's hemoglobin.

Abstract: A chemiresistive vapor sensor compound for detecting target vapors can comprise a perylene-tetracarboxylic diimide (PTCDI) core according to structure (I): where R can be a morphology control group or -A?-D?, A and A? can be independently a linking group, D and D? can be independently a strong electron donor which transfers electrons to the PTCDI core sufficient to form an anionic PTCDI radical of the PTCDI core, and R1 to R8 can be independently a side group. A chemiresistive vapor sensor for detection of a target compound can comprise an assembly of nanofibers formed of the chemiresistive sensor compound and a pair of electrodes operatively oriented about the assembly of nanofibers to allow electrical current to pass from a first electrode in the pair of electrodes through the assembly of nanofibers and to a second electrode in the pair of electrodes.

Abstract: A field effect transistor (FET) biosensor for virus detection of a selected virus within a sample volume is disclosed. The FET comprises a semiconductor substrate, a source and drain electrode on the substrate, the electrodes spaced to form a channel. A gate electrode carried on the substrate and located in the channel between the source and drain electrodes. An insulating layer is coupled to a top surface of the gate electrode and a bottom surface of the source and drain electrodes, with an open channel above the insulating layer. A channel material is coupled to the insulating layer. Aptamers are oriented within the open channel to bind to the channel material and with the selected virus to enable a detection of the selected virus by the FET biosensor based on a change in drain-source current at a selected gate voltage.

Abstract: Devices, systems, and methods for determining a distance between at least two points are disclosed and described, wherein interferometry technology is utilized to determine such distances.

Abstract: An MRI system uses a Cartesian-radial hybrid k-space trajectory to capture three-dimensional k-space data and reconstruct an image of an area of interest of a subject. The MRI system performs a series of k-space acquisitions to collect the data. A first k-space acquisition includes acquiring a two-dimensional EPI projection in a first plane parallel to a frequency-encoding direction and acquiring additional two-dimensional EPI projections in planes that are radially shifted about a center axis parallel to the frequency-encoding direction with respect to the first plane, until a selected number of projections are acquired. Each subsequent k-space acquisition includes acquiring an additional set of two-dimensional EPI projections in all of the planes in which an EPI projection was acquired during the first k-space acquisition, each additional set of EPI projections being shifted along a respective plane in a direction perpendicular to the frequency-encoding direction.

Abstract: Chemical probes and methods for detecting and/or quantifying hydrogen sulfide are disclosed. More particularly, this application discloses chemical probes and methods for their use for detecting and/or quantifying hydrogen sulfide in industrial and environmental samples and effluents, including samples of crude oil and sour water produced by petrochemical and other industrial processes.

Abstract: A thermoelectric material, having a formula TbxM1y-xM2zOw where M1 is one of Ca, Mg, Sr, Ba and Ra, M2 is at least one of Co, Fe, Ni, and Mn, x ranges from 0.01 to 5; y is 1, 2, 3, or 5; z is 1, 2, 3, or 4; and w is 1, 2, 3, 4, 5, 7, 8, 9, or 14. The thermoelectric material is chemically stable within 5% for one year and is also non-toxic. The thermoelectric material can also be incorporated into a thermoelectric system which can be used to generate electricity from waste heat sources or to cool an adjacent region.

Abstract: This invention discloses a design a capillary column for use with electrochemically modulated liquid chromatography (EMLC). The capillary design, which results in a marked reduction in the flow of current through the column, enables the use of a two-electrode column construction that overcomes the mechanical and electrical shortfalls of the conventional standard bore design.

Abstract: The present invention relates to synthetic analgesic peptides that are analogs of the ?-conotoxin peptide RgIA and their use for treating pain and other disorders.

Abstract: An ophthalmic composition or dosage form can include a therapeutically effective amount of a copper-containing agent that is sufficient to increase corneal lysyl oxidase activity in an eye of a subject in an amount sufficient to treat myopic progression and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat or prevent progression of myopia by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.

Abstract: A method of refining a microstructure of a titanium material can include providing a solid titanium material at a temperature below about 400° C. The titanium material can be heated under a hydrogen-containing atmosphere to a hydrogen charging temperature that is above a ? transus temperature of the titanium material and below a melting temperature of the titanium material, and held at this temperature for a time sufficient to convert the titanium material to a substantially homogeneous ? phase. The titanium material can be cooled under the hydrogen-containing atmosphere to a phase transformation temperature below the ? transus temperature and above about 400° C., and held for a time to produce ? phase regions. The titanium material can also be held under a substantially hydrogen-free atmosphere or vacuum at a dehydrogenation temperature below the ? transus temperature and above the ? phase decomposition temperature to remove hydrogen from the titanium material.

Abstract: Implementations of the present invention relate to apparatuses, systems, and methods for blocking, attenuating, or filtering neuroactive wavelengths of the visible light spectrum and reducing or preventing the symptoms affiliated with exposure to those wavelengths. Nanoparticles of a predetermined composition, size, and structure are dispersed in a host medium to create an optical notch filter, thereby attenuating only a narrow range of the visible spectrum.

Abstract: This invention discloses an approach is improve the strength and reproducibility of the signal generated in FTAs using solid-phase microextraction (SPME) through the design of an approach to generate the plasmonically-enhanced signal for SERS, surface-enhanced infrared (SEIRA), and other enhanced spectroscopies. The design incorporates: (1) a particle-particle coupling strategy that is triggered by the selective capture of an analyte to a particle that has been immobilized on a membrane and has been modified to act as a capture substrate; (2) the selective tagging of the captured analyte by a nanoparticle also designed to generate an amplified plasmonic signal upon tagging; and (3) the incorporation of an internal nanoparticle standard to account for fluctuations in flow rates and flow paths.

Abstract: This invention discloses a pretreatment approach for blood and bodily fluids to remove unwanted protein interferences in the measurement of analytes. Enzymes either contained in a cartridge or immobilized on a solid support break down proteins that complex with the analyte to shield it from detection. This pretreatment significantly enhances the detectability of analytes and does not require subsequent clean-up steps that would normally be required to ensure the functionality of the analysis method, thereby, creating a simple yet powerful approach for sample pretreatment in a variety of settings ranging from a complex laboratory infrastructure to a field deployable application.

Abstract: This invention discloses a design of microplates and microarrays to improve utility. The new design constructs a physical flux barrier that limits thermocapillary and other mass transfer contributions to the heterogeneous accumulation of reactant at the surface of a well or array address. The improved control of reactant delivery results in a much more uniform distribution of reactant across an address, thereby improving the accuracy of the measured response.